[vc_row row_content_width=”grid”][vc_column width=”1/2″][mkdf_elements_holder number_of_columns=”one-column” switch_to_one_column=”” alignment_one_column=””][mkdf_elements_holder_item]

Anti-FYa

[/mkdf_elements_holder_item][/mkdf_elements_holder][/vc_column][vc_column width=”1/2″][mkdf_elements_holder number_of_columns=”one-column” switch_to_one_column=”” alignment_one_column=””][mkdf_elements_holder_item][vc_column_text]

Description

[/vc_column_text]

The FYa and FYb antigens were reported in 1950 and 1951 respectively. Anti-FYa has been implemented in immediate and delayed Haemolytic Transfusion reactions and Haemolytic Disease in the new born. Indirect agglutination of red cells that carry the FYa – antigen occurs in the antiglobulin phase.  In the absence of the FYa– antigen, no indirect agglutination is generally observed.

The Biorex Diagnostics Anti-FYa reagent consists of human monoclonal antibodies diluted in phosphate buffer containing sodium chloride and bovine albumin. The reagent requires no further dilution or addition for recommended techniques.

[vc_empty_space height=”10px”][vc_column_text]

Get a quote

[/vc_column_text]

Add to Quote
[vc_empty_space height=”10px”][/mkdf_elements_holder_item][/mkdf_elements_holder][/vc_column][/vc_row][vc_row row_content_width=”grid”][vc_column][mkdf_elements_holder number_of_columns=”one-column” switch_to_one_column=”” alignment_one_column=””][mkdf_elements_holder_item][vc_empty_space height=”60px”][vc_column_text]

Specification

[/vc_column_text][vc_empty_space height=”10px”]

Product Name CAT.No Size
Anti-FYa BGFYA002 1 x 2ml
   
[/mkdf_elements_holder_item][/mkdf_elements_holder][/vc_column][/vc_row]

Unit 9A, The Technology Park,
Antrim, Co. Antrim
United Kingdom
BT41 1QS

Latest News

Quick Contact

Copyright 2022 Biorex Diagnostics. All Rights Reserved

Website by Front Creative

Biorex Diagnostics – Primary Diagnostics Innovation
Theme by Grace Themes